Novo Nordisk v. Bio-Technology General

This document cites

• Federal Cases - Regents of the University of California v. Eli Lilly & Co.
• Federal Cases - Cfmt Inc. v. Yieldup Intern. Corp., 01-1452.
• Federal Cases - Perseptive Biosystems Inc v. Pharmacia Biotech
• Federal Cases - Brasseler v. Stryker Sales
• Federal Cases - Bristol-Meyers Squibb Co. v. Ben Venue Laboratories Inc.



See all quotations

• Federal Cases - Amgen Inc. v. Hoechst Marion Roussel, Inc.
• Federal Cases - FMC Corp. v. Manitowoc Co., Inc.
• Federal Cases - Koito Mfg. Co., Ltd. v. Turn-Key-Tech, LLC
• Federal Cases - Enzo Biochem v. Calgene
• Federal Cases - Kingsdown Medical Consultants, Ltd. v. Hollister Inc.
• Federal Cases - Application of Hafner
• Federal Cases - Tegal Corporation v. Tokyo Electron America Inc.
• Federal Cases - King Instruments Corp. v. Perego, s. 91-1125
• Federal Cases - Smithkline Beecham Corp. v. Apotex Corp.
• Federal Cases - Schering Corp. v. Geneva Pharmaceuticals, 02-1540.
• Federal Cases - Purdue Pharma v. Boehring Ingelheim
• Federal Cases - Scripps Clinic & Research Foundation v. Genentech, Inc., Nos. 89-1541
• Federal Cases - Ak Steel Corp. v. Sollac and Ugine
• Federal Cases - Dayco Products, Inc. v. Total Containment, Inc.
• Federal Cases - Bruno Independent Living v. Acorn Mobility
• Federal Cases - Rasmusson v. Smithkline Beecham Corp.
• Federal Cases - Bristol-Myers Squibb v. Rhone-Poulenc Rorer
• US - Reference Stubs - Jurisdiction of the United States Court of Appeals for the Federal Circuit
• US - Reference Stubs - Civil action in case of derivation proceeding
• US - Reference Stubs - Specification
• US - Reference Stubs - Conditions for patentability; non-obvious subject matter
• US - Reference Stubs - Conditions for patentability; novelty